Letters
Long term statin treatment
Serious bias in 20 year follow-up study of statin trial
BMJ 2017; 359 doi: https://doi.org/10.1136/bmj.j4906 (Published 31 October 2017) Cite this as: BMJ 2017;359:j4906- Uffe Ravnskov, independent researcher1,
- Harumi Okuyama, professor2,
- Sherif Sultan, professor3
- 1Magle Stora Kyrkogata 9, 22350 Lund, Sweden
- 2Nagoya City University and Institute for Consumer Science and Human Life, Kinjo Gakuin University, Nagoya, Japan
- 3Western Vascular Institute, University Hospital Galway and Galway Clinic, National University of Ireland and Royal College of Surgeons of Ireland affiliated Hospital, Galway, Republic of Ireland
- ravnskov{at}tele2.se
The BMJ’s news story on the follow-up study of the WOSCOPS trial says that total and cardiovascular mortality were considerably reduced in men allocated to the treatment group at 20 year follow-up; in particular among those with the highest concentrations of low density lipoprotein (LDL) cholesterol.12
But the study has serious bias. …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.